Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837392 · ClinicalTrials.gov registry record · NA
Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03837392 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 30 participants.
The verdict
NCT03837392, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This protocol will test the hypothesis that Acceptance and Commitment Therapy (ACT) is effective in reducing anxiety and depressive symptoms during the perinatal and postpartum periods. Participants should expect their participation in the study to last 9-12 months.
Interventions
- DIAGNOSTIC_TEST Baseline Assessment (18-26 weeks pregnant)
- BEHAVIORAL Online Intervention and Phone Coaching Interventions
- DIAGNOSTIC_TEST Follow Up Assessments: 34-36 weeks pregnant and 4-week postpartum
- DIAGNOSTIC_TEST Follow Up Assessments: 8 weeks postpartum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03837392
The ClinicalTrials.gov registry entry for NCT03837392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Baseline Assessment (18-26 weeks pregnant) is the first listed.
NCT03837392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03837392 about?
NCT03837392 is a clinical study titled "Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety". This protocol will test the hypothesis that Acceptance and Commitment Therapy (ACT) is effective in reducing anxiety and depressive symptoms during the perinatal and postpartum periods. Participants should expect their participation in the study to last 9-12 months.
What is the current status of trial NCT03837392?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-06-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03837392?
The interventions under investigation include: Baseline Assessment (18-26 weeks pregnant) (DIAGNOSTIC_TEST), Online Intervention and Phone Coaching Interventions (BEHAVIORAL), Follow Up Assessments: 34-36 weeks pregnant and 4-week postpartum (DIAGNOSTIC_TEST), Follow Up Assessments: 8 weeks postpartum (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03837392?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.